Novocure (NVCR) 2025 Earnings Outlook and Analysis
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Daily volatility influences return paths and allocation choices. This primer covers interpretation and practical tweaks to targets and expectations.
25,212 articlesNovocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
SoFi's Mastercard collaboration could unlock more than just card revenue. This article explains why the deal might ex...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
Brent crude charts flashed a pattern not seen in 36 years, triggering fresh volatility bets. Analysts say the rarity ...
A new energy setback from the Iran conflict is reverberating worldwide. Global flows are disrupted, prices move, and ...
XRP has repeatedly rebounded despite jitters in the crypto space. This article uncovers the real reason keeps bouncin...
A sudden pullback in a high-profile space stock captured headlines. This article breaks down the factors behind intui...
Markets confront a rebalanced risk outlook as Iran signals it may push for nuclear concessions to survive. Investors ...
TeraWulf signs a 20-year deal with Anthropic for a 401 MW data center campus in Kentucky, locking in about $19 billio...
Honeywell slashed the price of a $1.92 billion chemicals acquisition by $500 million, a 26% concession tied to softer...
As GoodRx navigates evolving discount dynamics and a changing membership model, the 2025 earnings picture will hinge ...